Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Intended Use: In-vitro cell culture studies In-vivo preclinical research in approved animal models Laboratory investigation of biological mechanisms Academic and institutional research applications NOT Intended For: Human consumption or administration Therapeutic treatment or diagnosis Dietary supplementation Veterinary therapeutic applications without appropriate oversight Safety Protocols: Researchers should follow standard laboratory safety practices when handling Ipamorelin: Use appropriate personal protective equipment (lab coat, gloves, safety glasses) Handle in well-ventilated areas or fume hood Follow institutional biosafety guidelines Dispose of waste according to local regulations for biological/chemical waste Consult material safety data sheet (MSDS) for additional safety information
Unlike traditional anti-angiogenic therapies that target VEGF, Sylentis developed SYL1801, an siRNA targeting NOTCH Regulated Ankyrin Repeat Protein (NRARP), to prevent and control nAMD progression
Reported side effects are usually mild and can include temporary redness or irritation at the injection site, water retention, headache, or lightheadedness
M., Du, Y., Lou, J., Gurbuz, S., & Coskun, T
US$ 20.29
US$ 26.18
US$ 20.71
US$ 24.05
US$ 28.11
US$ 24.74
US$ 22.42
